<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">AIDS</journal-id><journal-id journal-id-type="iso-abbrev">AIDS</journal-id><journal-id journal-id-type="publisher-id">AIDS</journal-id><journal-title-group><journal-title>AIDS (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0269-9370</issn><issn pub-type="epub">1473-5571</issn><publisher><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">AIDS-D-20-00193</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000002555</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dauby</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="aff" rid="aff2"><sup>b</sup></xref><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Infectious Diseases, Centre Hospitalier Universitaire (CHU) Saint-Pierre</aff><aff id="aff2"><label>b</label>Centre for Environmental Health and Occupational Health, School of Public Health</aff><aff id="aff3"><label>c</label>Institute for Medical Immunology, Universit&#x000e9; Libre de Bruxelles (ULB), Brussels, Belgium.</aff><author-notes><corresp>Correspondence to Nicolas Dauby, MD, PhD, Department of Infectious Diseases, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. E-mail: <email>Nicolas_Dauby@stpierre-bru.be</email></corresp></author-notes><pub-date pub-type="ppub"><day>10</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>10</day><month>6</month><year>2020</year></pub-date><elocation-id>10.1097/QAD.0000000000002555</elocation-id><history><date date-type="received"><day>05</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>26</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><license license-type="NIH OGC"><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><self-uri xlink:href="aids-publish-ahead-of-print-10.1097.qad.0000000000002555.pdf"/><custom-meta-group><custom-meta><meta-name>PUBSTATE</meta-name><meta-value>POST-ACCEPTANCE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), agent of corona virus disease 2019 (COVID-19), has emerged in December 2019 in Wuhan, China and spread globally on all continents [<xref rid="R1" ref-type="bibr">1</xref>]. People living with HIV (PLWH) represent 37.9 million worldwide with a substantial proportion of the population in certain countries [<xref rid="R2" ref-type="bibr">2</xref>]. Notably, South Africa, where one out of five adults lives with HIV, has reported its first COVID-19 case on 5 March 2020 [<xref rid="R3" ref-type="bibr">3</xref>]. Incidence and severity of respiratory virus infection, such as influenza, is higher in PLWH as compared with HIV-uninfected patients. PLWH have an increased risk of hospitalization, more prolonged hospitalization and death following influenza infection [<xref rid="R4" ref-type="bibr">4</xref>].</p><p>Since the beginning of the 21st Century, two other coronaviruses have emerged as a cause of severe respiratory diseases: namely, SARS and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [<xref rid="R1" ref-type="bibr">1</xref>].</p><p>In order to identify previous clinical studies reporting outcome of PLWH following SARS or MERS-Cov infection, a PubMed search was performed using the MeSH terms &#x02018;Coronavirus&#x02019; or &#x02018;Middle East Respiratory Syndrome Coronavirus&#x02019; or &#x02018;SARS Virus&#x02019; and &#x02018;HIV&#x02019; or &#x02018;Acquired Immunodeficiency Syndrome&#x02019;. Large cohort studies of SARS-infected and MERS-CoV-infected patients were also reviewed for associated risk factors. References of relevant articles were screened. HIV-infection was not reported as a risk factor in large cohorts of SARS and MERS-CoV-infected patients [<xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R8" ref-type="bibr">8</xref>]. A case of SARS infection in a 30-year old Chinese man was reported in 2004 in this journal [<xref rid="R9" ref-type="bibr">9</xref>]. The patient was on antiretroviral therapy with lopinavir/ritonavir (LPV/RTV) and tenofovir, had a low CD4<sup>+</sup> count (134/&#x003bc;l) and a detectable viral load (470&#x0200a;copies/ml). The patient was treated with ribavirin and steroids and experienced a mild course, not requiring mechanical ventilation. The authors hypothesized that ART regimen could have influenced the course of the disease. Both in-vitro and historical studies suggested a possible antiviral activity of the protease inhibitor LPV/RTV against SARS infection. In a nonrandomized study, addition of LPV/RTV to ribavirin was associated with better outcome as compared with ribavirin alone [<xref rid="R10" ref-type="bibr">10</xref>]. Randomized control trials with LPV/RTV are currently ongoing in the treatment of COVID-19 [<xref rid="R11" ref-type="bibr">11</xref>]. However, recent in-vitro and animal studies in the MERS-CoV model indicated that LPV/RTV in combination with IFN-&#x003b2; is inferior to the antiviral agent remdesivir [<xref rid="R12" ref-type="bibr">12</xref>].</p><p>During the 2003 SARS outbreak, Chen <italic>et al.</italic>[<xref rid="R13" ref-type="bibr">13</xref>] reported that 19 AIDS patients treated for opportunistic infections in the same ward of SARS-infected patients did not develop nosocomial SARS infection despite long stay. This was in contrast with the high rate of infection in health-care workers (HCW) working on the same ward (21%). It could be hypothesized that distinct immune response might have impacted susceptibility to SARS infection. However, no definite conclusion regarding the possible interaction between HIV-infection and SARS can be drawn as exposure to infective viral particles is probably different between HCW and patients.</p><p>In conclusion, the experience from previous coronaviruses outbreaks on the susceptibility and severity of disease in PLWH is scarce. International collaborative studies are warranted in order to characterize the outcome of PLWH with COVID-19. This will facilitate the implementation of future preventive strategies such as immunization.</p><sec><title>Acknowledgements</title><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeri</surname><given-names>NC</given-names></name><name><surname>Shrestha</surname><given-names>N</given-names></name><name><surname>Rahman</surname><given-names>MS</given-names></name><name><surname>Zaki</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Bibi</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?</article-title>. <source><italic toggle="yes">Int J Epidemiol</italic></source>
<year>2020</year>; <comment>pii: dyaa033. doi: 10.1093/ije/dyaa033. [Epub ahead of print]</comment>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="other">UNAIDS. AIDS statistics&#x02014;2018 fact sheet. 2019.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="other">BNONews. Tracking coronavirus: MAP, data and timeline. Available at: <ext-link ext-link-type="uri" xlink:href="https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/">https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/</ext-link>. (Accessed 5 March 2020)</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>C</given-names></name><name><surname>Moyes</surname><given-names>J</given-names></name><name><surname>Tempia</surname><given-names>S</given-names></name><name><surname>Groom</surname><given-names>M</given-names></name><name><surname>Walaza</surname><given-names>S</given-names></name><name><surname>Pretorius</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009&#x02013;2011</article-title>. <source><italic toggle="yes">Emerg Infect Dis</italic></source>
<year>2013</year>; <volume>19</volume>:<fpage>1766</fpage>&#x02013;<lpage>1774</lpage>.<pub-id pub-id-type="pmid">24209781</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>CM</given-names></name><name><surname>Matukas</surname><given-names>LM</given-names></name><name><surname>Tomlinson</surname><given-names>GA</given-names></name><name><surname>Rachlis</surname><given-names>AR</given-names></name><name><surname>Rose</surname><given-names>DB</given-names></name><name><surname>Dwosh</surname><given-names>HA</given-names></name><etal/></person-group>
<article-title>Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto area</article-title>. <source><italic toggle="yes">JAMA</italic></source>
<year>2003</year>; <volume>289</volume>:<fpage>2801</fpage>&#x02013;<lpage>2809</lpage>.<pub-id pub-id-type="pmid">12734147</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>J</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Hung</surname><given-names>I</given-names></name><name><surname>Poon</surname><given-names>L</given-names></name><etal/></person-group>
<collab>HKU/UCH SARS Study Group</collab><article-title>Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study</article-title>. <source><italic toggle="yes">Lancet</italic></source>
<year>2003</year>; <volume>361</volume>:<fpage>1767</fpage>&#x02013;<lpage>1772</lpage>.<pub-id pub-id-type="pmid">12781535</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><name><surname>Najm</surname><given-names>H</given-names></name><name><surname>Aldawood</surname><given-names>AS</given-names></name><name><surname>Ghabashi</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection</article-title>. <source><italic toggle="yes">Ann Intern Med</italic></source>
<year>2014</year>; <volume>160</volume>:<fpage>389</fpage>&#x02013;<lpage>397</lpage>.<pub-id pub-id-type="pmid">24474051</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assiri</surname><given-names>A</given-names></name><name><surname>Al-Tawfiq</surname><given-names>JA</given-names></name><name><surname>Al-Rabeeah</surname><given-names>AA</given-names></name><name><surname>Al-Rabiah</surname><given-names>FA</given-names></name><name><surname>Al-Hajjar</surname><given-names>S</given-names></name><name><surname>Al-Barrak</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study</article-title>. <source><italic toggle="yes">Lancet Infect Dis</italic></source>
<year>2013</year>; <volume>13</volume>:<fpage>752</fpage>&#x02013;<lpage>761</lpage>.<pub-id pub-id-type="pmid">23891402</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>ATY</given-names></name><name><surname>Tsang</surname><given-names>OTY</given-names></name><name><surname>Wong</surname><given-names>MYF</given-names></name><name><surname>Lim</surname><given-names>WL</given-names></name><name><surname>Zheng</surname><given-names>BJ</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><etal/></person-group>
<article-title>Coronavirus infection in an AIDS patient</article-title>. <source><italic toggle="yes">AIDS Lond Engl</italic></source>
<year>2004</year>; <volume>18</volume>:<fpage>829</fpage>&#x02013;<lpage>830</lpage>.</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>CM</given-names></name><name><surname>Cheng</surname><given-names>VCC</given-names></name><name><surname>Hung</surname><given-names>IFN</given-names></name><name><surname>Wong</surname><given-names>MML</given-names></name><name><surname>Chan</surname><given-names>KH</given-names></name><name><surname>Chan</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</article-title>. <source><italic toggle="yes">Thorax</italic></source>
<year>2004</year>; <volume>59</volume>:<fpage>252</fpage>&#x02013;<lpage>256</lpage>.<pub-id pub-id-type="pmid">14985565</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>De Clercq</surname><given-names>E</given-names></name></person-group>
<article-title>Therapeutic options for the 2019 novel coronavirus (2019-nCoV)</article-title>. <source><italic toggle="yes">Nat Rev Drug Discov</italic></source>
<year>2020</year>; <volume>19</volume>:<fpage>149</fpage>&#x02013;<lpage>150</lpage>.<pub-id pub-id-type="pmid">32127666</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheahan</surname><given-names>TP</given-names></name><name><surname>Sims</surname><given-names>AC</given-names></name><name><surname>Leist</surname><given-names>SR</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>A</given-names></name><name><surname>Won</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>
<year>2020</year>; <volume>11</volume>:<fpage>222</fpage>.<pub-id pub-id-type="pmid">31924756</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XP</given-names></name><name><surname>Li</surname><given-names>GH</given-names></name><name><surname>Tang</surname><given-names>XP</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>XJ</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name></person-group>
<article-title>Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalized together</article-title>. <source><italic toggle="yes">J Acquir Immune Defic Syndr 1999</italic></source>
<year>2003</year>; <volume>34</volume>:<fpage>242</fpage>&#x02013;<lpage>243</lpage>.</mixed-citation></ref></ref-list></back></article>